Skip to Content

Carbidopa and Levodopa Extended-Release Tablets

Last Updated: March 27, 2020
Status: Resolved

Products Affected - Description
    • Sinemet CR extended release tablet, Merck, 25 mg/100 mg, bottle, 100 count, NDC 00006-3919-68 - discontinued
    • Sinemet CR extended release tablet, Merck, 50 mg/200 mg, bottle, 100 count, NDC 00006-3918-68 - discontinued
Reason for the Shortage
    • Accord has 50 mg/200 mg tablets available. Accord discontinued carbidopa and levodopa 25 mg/100 mg extended-release tablets.
    • Sun Pharma has carbidopa and levodopa extended-release tablets available.
    • Merck will be discontinuing Sinemet CR 50 mg/200 mg tablets around November 2019. The 25 mg/100 mg tablets will be discontinued around February 2020.
    • Mylan has carbidopa and levodopa extended-release tablets available.
Available Products
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, bottle, 100 count, NDC 16729-0079-01
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, bottle, 1000 count, NDC 16729-0079-17
    • Carbidopa and Levodopa extended release tablet, Mylan, 25 mg/100 mg, bottle, 100 count, NDC 00378-0088-01
    • Carbidopa and Levodopa extended release tablet, Mylan, 50 mg/200 mg, bottle, 100 count, NDC 00378-0094-01
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 25 mg/100 mg, unit-dose blister pack, 100 count, NDC 51079-0978-20
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 50 mg/200 mg, unit-dose blister pack, 100 count, NDC 51079-0923-20
    • Carbidopa and Levodopa extended release tablet, Sun Pharma, 25 mg/100 mg, 100 count, NDC 62756-0461-88
    • Carbidopa and Levodopa extended release tablet, Sun Pharma, 50 mg/200 mg, 100 count, NDC 62756-0457-88

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated March 27, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created September 28, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.